Short Interest in GelStat Corp. (OTCMKTS:GSAC) Declines By 14.3%

GelStat Corp. (OTCMKTS:GSAC) was the recipient of a significant decline in short interest in October. As of October 15th, there was short interest totalling 62,100 shares, a decline of 14.3% from the September 30th total of 72,500 shares. Based on an average trading volume of 8,851,200 shares, the days-to-cover ratio is currently 0.0 days.

GelStat Trading Up 14.3 %

Shares of OTCMKTS:GSAC traded up $0.00 during trading on Tuesday, hitting $0.00. 2,110,900 shares of the company were exchanged, compared to its average volume of 5,909,389. GelStat has a 1-year low of $0.00 and a 1-year high of $0.00.

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms.